
Clinical trials are at the heart of medical innovation. They help researchers test new treatments, improve existing ones, and discover cures for diseases. However, many people, particularly in underserved communities, are unaware of clinical trials or face significant barriers to participating in them. The PAN Foundation, a national healthcare advocacy organization, is tackling these challenges head-on through its Opening Doors to Clinical Trials initiative.
BlackDoctor.org spoke with Amy Niles, the Chief Mission Officer at the PAN Foundation, to discuss the importance of clinical trials, common misconceptions, and how the PAN Foundation is helping to break down barriers to participation.
Clinical trials are research studies conducted to evaluate the safety and effectiveness of new medical treatments, devices, or procedures. They are a crucial step in advancing healthcare, offering benefits such as:
Despite these benefits, many patients are not fully aware of clinical trials as a potential treatment option. Others may face challenges that prevent their participation.
Several factors discourage or prevent patients from considering clinical trials:
“Recently, we expanded our mission, which is to accelerate access to affordable, equitable healthcare,” Niles tells BlackDoctor.org
The PAN Foundation’s Opening Doors to Clinical Trials initiative aims to empower patients with the knowledge and resources to consider clinical trials as a viable treatment option. The program focuses on three key areas:
The PAN Foundation has launched a digital platform to help patients understand clinical trials. This website provides:
“We created clinicaltrials.PANfoundation.org to increase health literacy. The platform offers resources like stories from people like Bill [Allen], discussions on past practices that caused mistrust, and the progress made in clinical trials,” Niles says.
Finding the right clinical trial can be overwhelming. To make this easier, the PAN Foundation offers a user-friendly Trial Finder Tool. This tool helps patients navigate available trials and identify those that align with their treatment needs.
For patients who need additional guidance, PAN’s Companion Access Navigators are available to:
“Our goal is to empower patients to have conversations with their healthcare providers and consider clinical trials if it’s the right option for them,” Niles adds.
Historically, certain groups—such as racial and ethnic minorities, older adults, and people from rural areas—have been underrepresented in clinical trials. This lack of diversity can lead to treatments that are less effective or have unforeseen side effects in these populations.
The PAN Foundation is committed to ensuring that clinical trials reflect the diversity of the communities they serve. By educating underserved communities and addressing logistical barriers, the foundation is fostering a more inclusive approach to medical research.
“Many healthcare providers don’t bring up clinical trials due to time constraints, lack of knowledge, or other barriers,” Niles shares. “We want to understand these barriers better and provide resources to help healthcare teams, including nurses, financial navigators, and office staff, feel more equipped to discuss clinical trials with patients.”
Moving forward, PAN hopes to continue to increase patient access to clinical trials in the following ways:
If you or a loved one is considering a clinical trial, here are some steps to take:


By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.